Ki Hyeong Lee

17PUBLICATIONS
156CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 30, 2026
Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.

John H Strickler, Judith Raimbourg, Jonathan E Cohen

|Feb 17, 2026
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody.

Ben Tran, Mark Voskoboynik, Sang-We Kim

|Feb 06, 2026
JIN-A02, a Mutant-Selective Fourth-Generation EGFR Inhibitor, Overcomes C797S-Mediated Resistance and Demonstrates Intracranial Activity in NSCLC.

Eun Ji Lee, Ji Ae Ko, Min-Je Kim

|Oct 15, 2025
Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis.

Hongsik Kim, Minsuk Kwon, Sun Kyung Lee

|Oct 13, 2025
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.

Jeffrey D Bradley, Shunichi Sugawara, Ki Hyeong Lee

|Apr 09, 2025
Discordance in Claudin 18.2 Expression Between Primary and Metastatic Lesions in Patients With Gastric Cancer.

Seung-Myoung Son, Chang Gok Woo, Ok-Jun Lee

Pageof 3

Frequent Collaborators

4 joint publications

Myung-Ju Ahn

4 joint publications

Hee Kyung Kim

4 joint publications

James Chih-Hsin Yang

4 joint publications

Hye Sook Han